Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025)
Inventiva's (IVA) quarterly Other Non-Current Liabilities came in at $1.4 million in Q4 2025, up 25.93% year-on-year from $1.1 million in Q4 2024, and down 99.89% quarter-over-quarter from $1.3 billion in Q2 2025.
Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Inventiva's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 25.93% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 25.93% from the prior year.
- Other Non-Current Liabilities slipped to $1.4 million in Q4 2025 per IVA's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.3 billion in Q2 2025 and bottomed at $1.1 million in Q4 2024.
- The 4-year median for Other Non-Current Liabilities is $2.1 million (2021), against an average of $214.0 million.
- Across the five-year window, Other Non-Current Liabilities jumped 352.77% in 2021 and retreated 0.68% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $2.9 million in 2021, then plunged by 61.21% to $1.1 million in 2023, then retreated by 0.68% to $1.1 million in 2024, then climbed by 25.93% to $1.4 million in 2025.
- Per Business Quant, the three latest IVA Other Non-Current Liabilities figures stand at $1.4 million (Q4 2025), $1.3 billion (Q2 2025), and $1.1 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Jun 30, 2021 | 2.86 Mn |
| Mar 31, 2021 | 2.87 Mn |
| Dec 31, 2020 | 2.83 Mn |
| Jun 30, 2020 | 632,238.11 |
| Dec 31, 2019 | 635,353.52 |